RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma

出版年份 2015 全文链接

标题

作者

关键词

出版物

Volume 14, Issue 8, Pages 1939-1950

出版商

American Association for Cancer Research (AACR)

发表日期

2015-05-28

DOI

10.1158/1535-7163.mct-15-0076

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started